Oxaydo — Class III drug recall D-0094-2024
Ongoing recall by Zyla Life Sciences US Inc., reported 2023-11-15, distributed nationwide. Sub-potent Drug: Lower potency than labeled.
| Recall number | D-0094-2024 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Zyla Life Sciences US Inc., Lake Forest, IL, United States |
| Recall initiated | 2023-10-20 |
| Classified | 2023-11-08 |
| Reported by FDA | 2023-11-15 |
| Distributed | Nationwide (US) |
| Quantity | 3,792 bottles |
| Reason classes | labeling, potency |
| NDC | 69344-0113, 69344-0113-11, 69344-0213, 69344-0213-11 |
| Lot numbers | 22W02 |
| Expiration dates | 2025-01-31 |
Product
Oxaydo (oxycodone HCl, USP) tablets, 7.5 mg, 100 Tablets per bottle, Rx only, Distributed by: Zyla Life Sciences US Inc., Wayne, PA 19087. NDC: 69344-213-11
Reason for recall
Sub-potent Drug: Lower potency than labeled.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0094-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.